Immune interferon in the circulation of patients with autoimmune disease.
about
The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppressionCross-regulation of TNF and IFN-alpha in autoimmune diseasesMicroarray analysis of gene expression in lupusDirect Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint diseaseInterpreting interest in interferon-alphaCurrent and emerging treatment options in the management of lupusDisturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus ErythematosusKey issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implicationsIdentification of Candidate Predictors of Lupus FlareSexual dimorphism in autoimmunityContribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosusIRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosusEmerging therapies for systemic lupus erythematosus--focus on targeting interferon-alphaInterferon alpha-induced lupus: proof of principleGene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositisNetwork analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosusInterferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failureElevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosusLongitudinal expression of type I interferon responsive genes in systemic lupus erythematosus.Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus.TLRs and IFNs: critical pieces of the autoimmunity puzzleImmune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders.Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosusB cell lymphokines in human systemic lupus erythematosus.Crosstalk Between Apoptosis and Autophagy: Environmental Genotoxins, Infection, and Innate Immunity.Absence of immunoreactive interferon-alpha in CSF from patients with multiple sclerosis.Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus.New roles for the major human 3'-5' exonuclease TREX1 in human disease.Genetic regulation of serum cytokines in systemic lupus erythematosusInhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patientsInterferon-alpha: a therapeutic target in systemic lupus erythematosusA genomic approach to human autoimmune diseases.Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis.Type I interferon in the pathogenesis of lupus.Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitisThe unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies.Dendritic cells in systemic lupus erythematosusPivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis.
P2860
Q24299196-FF8BA988-BF2F-48D7-98E9-1C0030935B5EQ24556513-D130CF06-4444-485D-BEE9-E35BF900531DQ24795089-9FEEF278-553B-449D-868F-D6CCB9DA4ADEQ24796731-0D19B6AC-100D-45B7-AF9D-CEE78D2CD22FQ24797820-070627DD-D43D-49DC-B119-A665EB935F8CQ26741266-DDE9EC53-D9F4-44EE-924B-5C65538CEE7CQ26773124-7675D147-F7F3-4CBE-8638-B940895CF893Q26775756-F7AFED03-E8E1-4A4F-9C22-F82F3EEFCBF2Q26795372-A269669A-1113-4288-8A61-D455CDDD68BAQ28080459-FF67D75C-F3DC-487B-8947-76C5C8AF8B43Q28080920-B6DD17D8-53B1-4BC0-910D-07ABDB29FB06Q28253129-A4E8FDBD-1762-4452-A335-DA443226CD56Q28265144-27C0C2C7-CD6C-4C0B-ABA1-825D76D91241Q28282720-896701FB-DF74-4DF9-9F90-F906EF41B05AQ28287170-8E8D24F5-C821-400A-95DF-B799F7C962B2Q28301151-0C6E7A2E-03AB-4002-8059-F381B4855731Q30410652-029400BB-D143-4E1C-8C88-121831E7A57DQ30828464-CCDE0BE6-3EEB-4EFF-AF47-9431F2F3218DQ30873883-F0FE2508-5E37-4BE7-BC96-2D08A63030D2Q31080044-94175504-188A-4B31-9DC4-4B7348D53E03Q33354714-1A72750C-0675-4E98-A598-79EE3A6C98DEQ33554836-0225EB14-8003-4A74-A7C3-80B68CF3C5BDQ33555685-1B7A88D7-F0D8-4266-82B6-9AC5A58EE472Q33562175-2E1F0432-0490-484B-81AB-51AB1A5F85B4Q33565957-0667C2FE-E441-4F62-B081-1E7E75EDCF70Q33621871-7B05A405-0A5F-418C-AD33-0E70788A71CAQ33636927-CB8F12A5-5B02-48B6-AA92-36F15E5A33E5Q33637487-B036A099-84D0-454E-9BBE-77F02384BB2BQ33671295-1F5F60E1-CEE6-4978-B9B8-F8AB8F0B28C0Q33682879-BCAE1766-CCA8-4FD7-93EC-41DA782C4171Q33688996-B4EAB7AD-AEE1-418D-877C-F0ADC477B489Q33703923-57FD3EA1-355B-471A-9DD6-22A8C69F07AAQ33744320-4F234F88-2333-4EE4-9562-EC8AAB83DB72Q33762839-FE9B8AA6-019D-4108-B420-BECCD742A1A3Q33790174-0AB7D24E-0566-4BB6-AC8A-DADF279F645FQ33852174-FF7E8859-776A-4069-B42A-AA083670B042Q33907781-D4029D44-BE86-4283-9AA4-2138B9271E80Q33939981-838C8827-095E-4A74-87D9-8440BA4A2DCDQ33941433-E71FEE2B-8A29-4BB7-93D8-3163C44C7769Q33956662-D6C6FD3C-17DE-43DD-942E-46DBAEF5754E
P2860
Immune interferon in the circulation of patients with autoimmune disease.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Immune interferon in the circulation of patients with autoimmune disease.
@en
type
label
Immune interferon in the circulation of patients with autoimmune disease.
@en
prefLabel
Immune interferon in the circulation of patients with autoimmune disease.
@en
P2093
P1476
Immune interferon in the circulation of patients with autoimmune disease.
@en
P2093
P356
10.1056/NEJM197907053010102
P407
P577
1979-07-01T00:00:00Z